BCS Wealth Management Raises Stock Position in UnitedHealth Group Incorporated $UNH

BCS Wealth Management boosted its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 15.3% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,871 shares of the healthcare conglomerate’s stock after buying an additional 248 shares during the period. BCS Wealth Management’s holdings in UnitedHealth Group were worth $584,000 at the end of the most recent quarter.

Other large investors have also recently made changes to their positions in the company. Vanguard Group Inc. raised its holdings in UnitedHealth Group by 6.6% in the 1st quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate’s stock valued at $47,519,620,000 after acquiring an additional 5,583,343 shares during the last quarter. Wellington Management Group LLP increased its holdings in shares of UnitedHealth Group by 10.6% during the 1st quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate’s stock worth $13,537,859,000 after buying an additional 2,486,839 shares during the last quarter. GAMMA Investing LLC lifted its position in UnitedHealth Group by 56,142.1% in the first quarter. GAMMA Investing LLC now owns 8,295,153 shares of the healthcare conglomerate’s stock valued at $4,344,586,000 after buying an additional 8,280,404 shares during the last quarter. Bank of New York Mellon Corp boosted its position in shares of UnitedHealth Group by 2.5% during the 1st quarter. Bank of New York Mellon Corp now owns 8,128,174 shares of the healthcare conglomerate’s stock worth $4,257,131,000 after purchasing an additional 196,696 shares during the period. Finally, Nuveen LLC purchased a new position in shares of UnitedHealth Group in the first quarter valued at approximately $3,846,764,000. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of research firms have issued reports on UNH. Robert W. Baird reaffirmed an “underperform” rating and issued a $198.00 price target (down previously from $312.00) on shares of UnitedHealth Group in a research report on Thursday, July 31st. UBS Group reissued a “buy” rating on shares of UnitedHealth Group in a report on Thursday, July 17th. Piper Sandler decreased their price objective on UnitedHealth Group from $353.00 to $317.00 and set an “overweight” rating for the company in a report on Wednesday, July 30th. Sanford C. Bernstein lifted their target price on shares of UnitedHealth Group from $337.00 to $379.00 and gave the company an “outperform” rating in a report on Friday, September 5th. Finally, Bank of America raised their target price on shares of UnitedHealth Group from $290.00 to $325.00 and gave the stock a “neutral” rating in a research note on Monday, August 18th. Sixteen research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have assigned a Sell rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $358.95.

UnitedHealth Group Stock Performance

NYSE UNH opened at $351.87 on Thursday. The company has a market capitalization of $318.68 billion, a P/E ratio of 15.25, a PEG ratio of 2.27 and a beta of 0.45. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85. UnitedHealth Group Incorporated has a 1-year low of $234.60 and a 1-year high of $630.73. The business has a 50 day moving average price of $298.81 and a 200 day moving average price of $362.32.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). The business had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The business’s revenue was up 12.9% on a year-over-year basis. During the same quarter in the previous year, the firm posted $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Sell-side analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were given a dividend of $2.21 per share. The ex-dividend date was Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a yield of 2.5%. UnitedHealth Group’s dividend payout ratio (DPR) is 38.30%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.